חזרה לתוצאות החיפוש

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Advanced Solid Tumors

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora, Colorado, United States

    Contact: Study coordinator (Ashley Fisher) · ASHLEY.R.FISHER@CUANSCHUTZ.EDU
    Contact: Principal Investigator (Antonio Jimeno)

  • Sarah Cannon Research Institute (SCRI) at HealthONE, Denver, Colorado, United States

    Contact: Study coordinator (Jason Henry) · Jason.Henry2@sarahcannon.com
    Contact: Principal Investigator (Jason Henry)

  • Yale School of Medicine - Yale Cancer Center - Smilow Cancer Hospital Care Centers - North Haven, North Haven, Connecticut, United States

    Contact: Study coordinator (Anastasio Gabrielle) · gabrielle.anastasio@yale.edu
    Contact: Principal Investigator (Michael Cecchini)

  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida, United States

    Contact: Study coordinator (Elizabeth Gilmore) · Elizabeth.Griffith@scri.com
    Contact: Principal Investigator (Cesar Perez)

  • Florida Cancer Specialists & Research Institute (FCS) - Sarasota Cattlemen Office, Sarasota, Florida, United States

    Contact: Study coordinator (Carly Taylor) · ctaylor@flcancer.com
    Contact: Principal Investigator (Manish Patel)

  • Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley, Las Vegas, Nevada, United States

  • University of Cincinnati Vontz Center for Molecular Studies, Cincinnati, Ohio, United States

  • The University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Coordinator Clinical operation director) · RA@medilinkthera.com

  • NEXT Oncology - Houston, Houston, Texas, United States

  • NEXT Oncology - Dallas, Irving, Texas, United States

    Contact: Study coordinator (Erica Torres) · etorres@nextoncology.com
    Contact: Principal Investigator (Shiraj Sen)

  • NEXT San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Coordinator Clinical operation director) · RA@medilinkthera.com

  • Gosford Hospital, Gosford, New South Wales, Australia

  • One Clinical Research - Nedlands, Nedlands, Western Australia, Australia

  • Monash Health, Melbourne, Australia

    Contact: Study coordinator (Sophia Frentzas) · sophia.frentzas@monash.edu
    Contact: Principal Investigator (Sophia Frentzas)

  • Princess Margaret Hospital, Toronto, Toronto, Canada

    Contact: Study coordinator (Albiruni Razak) · Albiruni.razak@uhn.ca
    Contact: Principal Investigator (Albiruni Razak)

  • The Ottawa Hospital - General Campus, Ottawa, Canada

    Contact: Study coordinator (Jura Nakamura) · junakamura@ohri.ca
    Contact: Principal Investigator (Scott Laurie)

  • China-Japan Friendship Hospital, Beijing, Beijing Municipality, China

  • The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

  • Wenzhou Medical University - The First Affiliated Hospital, Wenzhou, Zhejiang, China

  • West China Hospital, Sichuan University, Chengdu, China

    Contact: Study coordinator (Yan Zhang) · 18980601166@qq.com
    Contact: Principal Investigator (Yan Zhang)

  • Sun Yat-sen University Cancer Center, Guangzhou, China

    Contact: Study coordinator (Danyun Ruan) · ruandy1@sysucc.org.cn
    Contact: Principal Investigator (Ruihua Xu)
    Danyun Ruan (Sub-investigator)
צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)